qs_id,statement_number,statement
QS93,1,Adults with non‑valvular atrial fibrillation and a CHA2DS2-VASC stroke risk score of 2 or above are offered anticoagulation.
QS93,2,Adults with atrial fibrillation are not prescribed aspirin as monotherapy for stroke prevention.
QS93,3,Adults with atrial fibrillation who are prescribed anticoagulation discuss the options with their healthcare professional at least once a year.
QS93,4,Adults with atrial fibrillation taking a vitamin K antagonist who have poor anticoagulation control have their anticoagulation reassessed.
QS93,5,Adults with atrial fibrillation whose treatment fails to control their symptoms are referred for specialised management within 4 weeks.
QS93,6,"Developmental quality statements set out an emergent area of cutting‑edge service delivery or technology currently found in a minority of providers and indicating outstanding performance. They will need specific, significant changes to be put in place, such as redesign of services or new equipment."
